Fulgent Genetics, Inc. (FLGT)
20.62
-1.06
(-4.89%)
USD |
NASDAQ |
Oct 30, 16:00
20.58
-0.04
(-0.22%)
After-Hours: 20:00
Fulgent Genetics Enterprise Value : 314.30M for Oct. 30, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 314.30M |
| October 29, 2026 | 343.46M |
| October 28, 2026 | 339.06M |
| October 27, 2026 | 316.50M |
| October 26, 2026 | 303.29M |
| October 23, 2026 | 299.99M |
| October 22, 2026 | 296.96M |
| October 21, 2026 | 300.81M |
| October 20, 2026 | 306.32M |
| October 19, 2026 | 299.99M |
| October 16, 2026 | 292.01M |
| October 15, 2026 | 334.11M |
| October 14, 2026 | 325.03M |
| October 13, 2026 | 326.40M |
| October 12, 2026 | 337.68M |
| October 09, 2026 | 345.11M |
| October 08, 2026 | 319.80M |
| October 07, 2026 | 312.92M |
| October 06, 2026 | 313.20M |
| October 05, 2026 | 364.65M |
| October 02, 2026 | 337.96M |
| October 01, 2026 | 333.01M |
| September 30, 2026 | 352.82M |
| September 29, 2026 | 354.47M |
| September 28, 2026 | 362.17M |
| Date | Value |
|---|---|
| September 25, 2026 | 357.77M |
| September 24, 2026 | 339.89M |
| September 23, 2026 | 332.18M |
| September 22, 2026 | 342.64M |
| September 21, 2026 | 339.61M |
| September 18, 2026 | 343.74M |
| September 17, 2026 | 348.14M |
| September 16, 2026 | 342.09M |
| September 15, 2026 | 332.46M |
| September 14, 2026 | 315.12M |
| September 11, 2026 | 309.62M |
| September 10, 2026 | 300.54M |
| September 09, 2026 | 293.11M |
| September 08, 2026 | 302.74M |
| September 04, 2026 | 289.81M |
| September 03, 2026 | 287.61M |
| September 02, 2026 | 298.34M |
| September 01, 2026 | 285.96M |
| August 31, 2026 | 279.90M |
| August 28, 2026 | 286.51M |
| August 27, 2026 | 295.86M |
| August 26, 2026 | 292.01M |
| August 25, 2026 | 295.86M |
| August 24, 2026 | 282.10M |
| August 21, 2026 | 294.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 33.59B |
| Labcorp Holdings, Inc. | 35.88B |
| OPKO Health, Inc. | 1.336B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.554B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.72M |
| Revenue (Quarterly) | 85.39M |
| Total Expenses (Quarterly) | 114.92M |
| EPS Diluted (Quarterly) | -1.054 |
| Gross Profit Margin (Quarterly) | 27.02% |
| Profit Margin (Quarterly) | -34.80% |
| Earnings Yield | -13.72% |
| Normalized Earnings Yield | -13.09 |